Delfi Diagnostics: Liz Homans
Delfi Diagnostics has appointed Liz Homans to its board of directors. Homans is currently CEO of Lyell Immunopharma, which she joined when it was founded in 2018. She later served as the company's president prior to becoming CEO in 2020. Before that she held multiple senior leadership positions at Genentech from 2009 to 2018, including VP of US sales. Homans received an MBA from Columbia University and a BA in German and economics from Bates University.